Renew interest for Health Stocks?_老虎社区_美港股上老虎

Renew interest for Health Stocks?

Ryanccs75
2021-11-27

With the new variant of concern discovered in Africa, called Omicron, there have been preliminary evidence to show increased risk of reinfection. Wouldn't this give everyone a rethink of the need for health stock like $TOP GLOVE CORPORATION BHD(BVA.SI)$$MEDTECS INTERNATIONAL CORP LTD(546.SI)$These stocks have been battered long enough and clearly have been oversold. Particularly $TOP GLOVE CORPORATION BHD(BVA.SI)$, a company that posted a historic net profit of RM7.87bil for the financial year ended Aug 31, 2021. FY21 net profit jumped 350% from RM1.75bil in FY20. Sales Revenue rose 127% to RM16.40bil from FY2020. Dividend yield more than 20%.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

yongts
·2021-11-27
agree totally. but uob analysts 2 days ago still putting out bad news amid old recycled news about falling expected ASP( by the way asp did not so much as they speculated).& vaccination work
回复
点赞
举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":877406864,"tweetId":"877406864","gmtCreate":1637967252120,"gmtModify":1637967591378,"author":{"id":3582590747075727,"idStr":"3582590747075727","authorId":3582590747075727,"authorIdStr":"3582590747075727","name":"Ryanccs75","avatar":"https://static.tigerbbs.com/db06a5e32c356572e05bd0d3f0e0dd8c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":88,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"Renew interest for Health Stocks?","extraTitle":"","html":"<html><head></head><body><p>With the new variant of concern discovered in Africa, called Omicron, there have been preliminary evidence to show increased risk of reinfection. Wouldn't this give everyone a rethink of the need for health stock like&nbsp;<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a><a href=\"https://laohu8.com/S/546.SI\">$MEDTECS INTERNATIONAL CORP LTD(546.SI)$</a>These stocks have been battered long enough and clearly have been oversold. Particularly&nbsp;<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a>, a company that&nbsp;posted a historic net profit of RM7.87bil for the financial year ended Aug 31, 2021. FY21 net profit jumped 350% from RM1.75bil in FY20. Sales Revenue rose 127% to RM16.40bil from FY2020. Dividend yield more than 20%.</p></body></html>","htmlText":"<html><head></head><body><p>With the new variant of concern discovered in Africa, called Omicron, there have been preliminary evidence to show increased risk of reinfection. Wouldn't this give everyone a rethink of the need for health stock like&nbsp;<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a><a href=\"https://laohu8.com/S/546.SI\">$MEDTECS INTERNATIONAL CORP LTD(546.SI)$</a>These stocks have been battered long enough and clearly have been oversold. Particularly&nbsp;<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a>, a company that&nbsp;posted a historic net profit of RM7.87bil for the financial year ended Aug 31, 2021. FY21 net profit jumped 350% from RM1.75bil in FY20. Sales Revenue rose 127% to RM16.40bil from FY2020. Dividend yield more than 20%.</p></body></html>","text":"With the new variant of concern discovered in Africa, called Omicron, there have been preliminary evidence to show increased risk of reinfection. Wouldn't this give everyone a rethink of the need for health stock like $TOP GLOVE CORPORATION BHD(BVA.SI)$$MEDTECS INTERNATIONAL CORP LTD(546.SI)$These stocks have been battered long enough and clearly have been oversold. Particularly $TOP GLOVE CORPORATION BHD(BVA.SI)$, a company that posted a historic net profit of RM7.87bil for the financial year ended Aug 31, 2021. FY21 net profit jumped 350% from RM1.75bil in FY20. Sales Revenue rose 127% to RM16.40bil from FY2020. Dividend yield more than 20%.","highlighted":1,"essential":1,"paper":2,"likeSize":12,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/877406864","repostId":0,"isVote":1,"tweetType":1,"viewCount":3312,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BVA.SI","546.SI"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":554,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":6740617,"commentId":"6740617","gmtCreate":1637975431991,"gmtModify":1637979403393,"authorId":3560932213300008,"author":{"id":3560932213300008,"idStr":"3560932213300008","authorId":3560932213300008,"name":"yongts","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":877406864,"objectIdStr":"877406864","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"agree totally. but uob analysts 2 days ago still putting out bad news amid old recycled news about falling expected ASP( by the way asp did not so much as they speculated).&amp; vaccination work","text":"agree totally. but uob analysts 2 days ago still putting out bad news amid old recycled news about falling expected ASP( by the way asp did not so much as they speculated).&amp; vaccination work","html":"agree totally. but uob analysts 2 days ago still putting out bad news amid old recycled news about falling expected ASP( by the way asp did not so much as they speculated).&amp; vaccination work","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

Renew interest for Health Stocks?

评论（4）

热议股票